Cardiovascular disease aspirin evidence that aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Blood Platelets Endothelium, Vascular Cardiovascular System Carotid Arteries Gastric Mucosa

Diseases32

Cardiovascular Diseases Hypertension Atherosclerosis Stroke Myocardial Infarction Coronary Disease Diabetes Mellitus, Type 2 Metabolic Syndrome X Obesity Diabetes Mellitus Hemorrhage Thrombosis Dyslipidemias Asthma, Aspirin-Induced Diabetic Angiopathies Coronary Artery Disease Gastrointestinal Hemorrhage Inflammation Diabetes Complications Cerebrovascular Disorders Hyperlipidemias Hypercholesterolemia Kidney Failure, Chronic Vascular Diseases Arteriosclerosis Myocardial Ischemia Chronic Disease Reye Syndrome Insulin Resistance Calcinosis Stomach Ulcer Heart Diseases

Chemicals and Drugs41

Aspirin Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Thromboxane B2 Cyclooxygenase Inhibitors Salicylates Biological Markers Fibrinolytic Agents Sodium Salicylate Anticoagulants C-Reactive Protein Warfarin Cyclooxygenase 1 Tablets, Enteric-Coated Cholesterol Prostaglandin-Endoperoxide Synthases Lipids Thromboxane A2 Cardiovascular Agents Cyclooxygenase 2 Inhibitors Thromboxanes Hydroxymethylglutaryl-CoA Reductase Inhibitors Cholesterol, LDL Ibuprofen Homocysteine Cholesterol, HDL Hypolipidemic Agents Dipyridamole Triglycerides Lipoxins Acetaminophen Blood Glucose Cyclooxygenase 2 Indomethacin Antihypertensive Agents Sulfinpyrazone Prostaglandins Fibrinogen Antioxidants Naproxen

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Risk Factors Prospective Studies Cohort Studies Platelet Function Tests Risk Assessment Follow-Up Studies Drug Therapy, Combination Blood Pressure Incidence Proportional Hazards Models Risk Cross-Sectional Studies Prevalence Obesity Double-Blind Method Treatment Outcome Body Mass Index Bleeding Time Cause of Death Randomized Controlled Trials as Topic Case-Control Studies Odds Ratio Multivariate Analysis Predictive Value of Tests Logistic Models Questionnaires Mortality Longitudinal Studies Cross-Over Studies Regression Analysis Retrospective Studies Carotid Intima-Media Thickness Prognosis

Psychiatry and Psychology3

Smoking Life Style Risk Reduction Behavior

Phenomena and Processes17

Platelet Aggregation Blood Pressure Time Factors Risk Obesity Dose-Response Relationship, Drug Platelet Activation Body Mass Index Bleeding Time Diet Odds Ratio Drug Resistance Oxidative Stress Drug Interactions Insulin Resistance Carotid Intima-Media Thickness Exercise

Anthropology, Education, Sociology and Social Phenomena2

Sex Distribution Exercise

Information Science5

Incidence Prevalence Cause of Death Questionnaires Mortality

Named Groups1

European Continental Ancestry Group

Health Care32

Risk Factors Prospective Studies Cohort Studies Risk Assessment Follow-Up Studies Primary Prevention Incidence Proportional Hazards Models Risk Cross-Sectional Studies Prevalence Double-Blind Method Treatment Outcome Sex Factors Body Mass Index Age Factors Cause of Death Randomized Controlled Trials as Topic Case-Control Studies Odds Ratio Multivariate Analysis Comorbidity Predictive Value of Tests Logistic Models Questionnaires Secondary Prevention Mortality Sex Distribution Longitudinal Studies Cross-Over Studies Regression Analysis Retrospective Studies

Geographicals2

United States Japan

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Aspirin Cardiovascular Diseases Platelet Aggregation Inhibitors Risk Factors Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Thromboxane B2 Platelet Aggregation Cyclooxygenase Inhibitors Prospective Studies Cohort Studies Platelet Function Tests Salicylates Risk Assessment Hypertension Follow-Up Studies Atherosclerosis Drug Therapy, Combination Stroke Biological Markers Blood Platelets Primary Prevention Myocardial Infarction Blood Pressure Incidence Time Factors Coronary Disease Proportional Hazards Models Fibrinolytic Agents Diabetes Mellitus, Type 2 Metabolic Syndrome X Sodium Salicylate Risk Cross-Sectional Studies Prevalence Obesity Double-Blind Method Diabetes Mellitus United States Treatment Outcome Anticoagulants C-Reactive Protein Dose-Response Relationship, Drug Hemorrhage Thrombosis Platelet Activation Sex Factors Warfarin Dyslipidemias Body Mass Index Asthma, Aspirin-Induced Cyclooxygenase 1 Diabetic Angiopathies Age Factors Smoking Coronary Artery Disease Tablets, Enteric-Coated Gastrointestinal Hemorrhage Bleeding Time Cholesterol Prostaglandin-Endoperoxide Synthases Inflammation Lipids Life Style Cause of Death Diabetes Complications Thromboxane A2 Randomized Controlled Trials as Topic Cardiovascular Agents Cyclooxygenase 2 Inhibitors Thromboxanes Hydroxymethylglutaryl-CoA Reductase Inhibitors Cerebrovascular Disorders Endothelium, Vascular Case-Control Studies Cholesterol, LDL Ibuprofen Homocysteine Diet Odds Ratio Cholesterol, HDL Multivariate Analysis Hypolipidemic Agents Dipyridamole Cardiovascular System Hyperlipidemias Hypercholesterolemia Kidney Failure, Chronic Drug Resistance Japan Triglycerides Vascular Diseases Comorbidity Predictive Value of Tests Lipoxins Arteriosclerosis Acetaminophen Blood Glucose Cyclooxygenase 2 Logistic Models

No FAQ available that match "cardiovascular disease aspirin evidence that aspirin"